Projects per year
Fingerprint
Dive into the research topics where Shamez Ladhani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
A Phase II, randomised, single-blind, platform trial to assess safety, reactogenicity and immunogenicity of COVID-19 vaccines in pregnant women in the United Kingdom
Heath, P. T. (PI), Jones, C. E. (CoPI), Galiza, E. (CoPI), Ledoare, K. K. (CoPI), Wan, M. (CoPI), Ladhani, S. (CoPI), Liu, X. (CoPI) & Khalil, A. (CoPI)
National Institute for Health and Care Research
1/07/21 → 31/10/24
Project: Research
-
Non-hospitalised Children & young people (CYP) with Long Covid (The CLoCk Study)
Stephenson, T. (PI), Hargreaves, D. S. (CoPI), Whittaker, E. (CoPI), Heyman, I. (CoPI), Sharma, K. (CoPI), Buszewicz, M. (CoPI), Swann, O. V. (CoPI), Garg, S. (CoPI), Segal, T. Y. (CoPI), Poustie, V. (CoPI), Dalrymple, E. (CoPI), Harnden, A. (CoPI), De Stavola, B. (CoPI), Crawley, E. (CoPI), Semple, M. G. (CoPI), Levin, M. (CoPI), Shafran, R. (CoPI), Ladhani, S. (CoPI), Ford, T. (CoPI) & Chalder, T. (CoPI)
1/04/21 → 31/03/24
Project: Research
-
Non-hospitalised Children & young people (CYP) with Long Covid (The CLoCk Study)
Whittaker, E. (CoPI), Sharma, K. (CoPI), Dalrymple, E. (CoPI), De Stavola, B. (CoPI), Ford, T. (CoPI), Heyman, I. (CoPI), Shafran, R. (CoPI), Buszewicz, M. (CoPI), Shafran, R. (CoPI), Ladhani, S. (CoPI), Garg, S. S. (CoPI), Crawley, E. (CoPI), Garg, S. (CoPI) & Levin, M. (CoPI)
27/02/21 → 30/03/24
Project: Research
-
Integrating genomic surveillance and ecological modelling to maximise pneumococcal vaccine efficacy
Croucher, N. J. (PI), Miller, L. (CoPI), Fry, N. (CoPI), Ladhani, S. (CoPI), Lees, J. (CoPI) & Flasche, S. (CoPI)
14/06/20 → 14/12/23
Project: Research
-
Ability of the MenB-fHbp vaccine to provide immune protection against meningococcal serogroup B ST-1161 UK university “South West Outbreak” strain isolates
Lucidarme, J., Clark, S. A., Borrow, R., Murthy, A. K., Tan, C., Naqvi, R., Ladhani, S. N. & Findlow, J., 30 Apr 2026, In: Vaccine. 80, 128503.Research output: Contribution to journal › Article › peer-review
Open Access -
Assessing the potential impact of the 20-valent (PCV20) and an adult 21-valent (aPCV21) pneumococcal conjugate vaccine on invasive pneumococcal disease in England
Nikhab, A., Patel, T., Rooney, G., Wasti, S., Abdullahi, F., D'Aeth, J. C., Eletu, S., Litt, D. & Ladhani, S. N., 7 Mar 2026, In: Vaccine. 75, p. 128246 128246.Research output: Contribution to journal › Article › peer-review
Open Access -
COVID-19 hospitalizations in women of childbearing age and children during the Omicron period, January 2023 to September 2024
Lewis, L., Mohammed, D., Evans, L., Patterson, B., Lee, K., Galiza, E., Zsigmond, B., Khalil, A., Heath, P. & Ladhani, S. N., Aug 2026, In: International Journal of Infectious Diseases. 169, 108746.Research output: Contribution to journal › Article › peer-review
Open Access -
Current knowledge and future perspectives on management and prevention of group B streptococcus in neonates and young infants
Young, A. N., Karampatsas, K., Ladhani, S. N., Lamagni, T. L., Le Doare, K., Peacock, J., Thorn, N. & Heath, P. T., Mar 2026, In: Archives of Disease in Childhood: Fetal and Neonatal Edition.Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023
Foster, K., Heymer, E. J., Campbell, H., Wilson, E., Baldasera, J., Lucidarme, J., Clark, S. A., Bai, X., Ahmad, S., Borrow, R. & Ladhani, S. N., 22 Jan 2026, In: Eurosurveillance. 31, 3Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus)